Sienna Biopharmaceuticals (SNNAQ) Short Interest Ratio & Short Volume

Short interest is the volume of Sienna Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,000 shares of SNNAQ short. Learn More on Sienna Biopharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNNAQ shares currently have a short interest ratio of 10.0. Learn More on Sienna Biopharmaceuticals's short interest ratio.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sienna Biopharmaceuticals: Alvotech (0.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling SNNAQ is an investing strategy that aims to generate trading profit from Sienna Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sienna Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNNAQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNNAQ, twice per month. The most recent reporting period available is October, 31 2024.